Procurement Summary
Country: USA
Summary: Notice of Intent to Sole Source Lease of Avatar Odyssey Instruments Xcell Biosciences
Deadline: 10 Apr 2026
Posting Date: 02 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 138867993
Document Ref. No.: 26-004627
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Notice of Intent to Sole Source - Lease of Avatar™ Odyssey Instruments (Xcell Biosciences)
NAICS Code: 532490 - Other Commercial and Industrial Machinery and Equipment Rental and Leasing
Product Service Code (PSC):W066 - Lease or Rental of Equipment - Laboratory Equipment
Description:
This is a Notice of Intent, not a request for quotations. A solicitation will not be issued, and quotations will not be requested. This notice is for informational purposes only.
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), Clinical Center (CC), Office of Purchasing and Contracts, on behalf of the Center for Cellular Engineering (CCE), intends to award a firm-fixed-price contract on a sole source basis to:
Xcell Biosciences, Inc.
455 Mission Bay Blvd Suite 124
San Francisco, California 94158-2159
Requirement:
The purpose of this acquisition is to lease four (4) Avatar™ Odyssey instruments for a period of six (6) months to support process development activities within the CCE laboratories located at the NIH Clinical Center, Bethesda, Maryland.
These instruments enable precise control of cellular microenvironment conditions, including oxygen tension (hypoxia to normoxia), pressure, and temperature, which are critical for evaluating and optimizing cell therapy manufacturing processes.
The Center for Cellular Engineering develops and manufactures investigational cell-based therapies for patients with limited or no remaining standard treatment options, in compliance with Current Good Manufacturing Practice (cGMP) requirements (21 CFR Parts 210, 211, 600, and 1271).
Although the instruments are designated for research use only and will not be used for clinical manufacturing, they are essential for generating data that will inform process optimization, improve cell phenotype and function, and support future acquisition of GMP-compliant systems.
Authority:
FAR 13.106-1(b)(1) - Soliciting from a single sourc...
Notice ID: 26-004627
Department/Ind. Agency: health and human services, department of
Sub-tier: national institutes of health
Office: national institutes of health olao
Product Service Code: w066 - lease or rental of equipment- instruments and laboratory equipment
NAICS Code: 532490 - Other Commercial and Industrial Machinery and Equipment Rental and Leasing
Inactive Dates: apr 11, 2026
Inactive Policy: manual
Documents
Tender Notice